Insight: As FDA delays Novavax' COVID vaccine approval, patients fight back

  • Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F. Kennedy Jr cast doubt on its efficacy.